Edgewise Therapeutics, Inc. (EWTX)
Pharmaceutical Preparations
Latest Price
$38.43
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
4.60
P/B Ratio
8.35
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 15.52M | $488.0M | 14.44% | -- | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 10.43M | $328.0M | 9.70% | -- | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 7.37M | $231.0M | 6.85% | +823.8K | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 6.58M | $207.0M | 6.12% | -- | 2026-03-31 |
| BlackRock, Inc. | 6.47M | $203.0M | 6.02% | -157.6K | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 5.92M | $186.0M | 5.50% | +1.35M | 2026-03-31 |
| NOVO HOLDINGS A/S | 5.35M | $168.0M | 4.98% | -- | 2026-03-31 |
| Driehaus Capital Management LLC | 4.48M | $141.0M | 4.17% | -- | 2026-03-31 |
| Siren, L.L.C. | 4.43M | $139.0M | 4.12% | -99.7K | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 4.42M | $139.0M | 4.12% | -34.0K | 2026-03-31 |